Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$0.99 - $1.46 $0 - $0
0 New
0 $0
Q4 2023

Feb 07, 2024

BUY
$0.6 - $2.18 $0 - $0
0 New
0 $0
Q3 2023

Oct 30, 2023

BUY
$1.72 - $2.45 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023

BUY
$1.72 - $2.45 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023

BUY
$1.89 - $2.92 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023

BUY
$2.2 - $3.4 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023

BUY
$1.85 - $2.69 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022

BUY
$0.28 - $2.89 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022

BUY
$1.3 - $2.63 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022

BUY
$1.25 - $3.97 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022

BUY
$2.4 - $5.01 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021

BUY
$2.62 - $9.25 $0 - $0
0 New
0 $0

About PetVivo Holdings, Inc.


  • Ticker PETV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,072,000
  • Market Cap $4.73M
  • Description
  • PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint affliction...
More about PETV
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.